Open Access Highly Accessed Email this article to a friend

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Yumi Asukai*†, Amparo Valladares†, Carlos Camps†, Eifiona Wood†, Kaisa Taipale†, Jorge Arellano, Alejo Cassinello, José A Sacristán and Tatiana Dilla

BMC Cancer 2010, 10:26 doi:10.1186/1471-2407-10-26

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?